Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_assertion type Assertion NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_head.
- NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_assertion description "[The finding that E-cadh-mediated AJ formation contributes to PI3K/AKT activation in EOC cells by a mechanism that appears to be restricted to these cells provides the underpinning for therapeutic strategies that exploit PI3K inhibition to halt EOCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_provenance.
- NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_assertion evidence source_evidence_literature NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_provenance.
- NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_assertion SIO_000772 19151754 NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_provenance.
- NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_assertion wasDerivedFrom befree-20140225 NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_provenance.
- NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_assertion wasGeneratedBy ECO_0000203 NP160934.RAJTP4eDDZ5WvgJaYh2LNgPBZCi-RP9F2FBxagAqmorzs130_provenance.